Treatment should be limited to patients with any of the following: Symptomatic osteomalacia (unrelated to aluminum) Secondary hyperparathyroidism Postparathyroidectomy hypocalcemia Although oral calcitriol is often given along with oral calcium to suppress secondary hyperparathyroidism, the results are variable in patients with end-stage renal disease.